Stephanie Torres
@stephanietr612.bsky.social
680 followers
110 following
24 posts
🇵🇷 Puerto Rican in Dallas, TX📍| Nephrology Assistant Professor UTSW | #NephSky
Posts
Media
Videos
Starter Packs
Change is in the Autumn air 🌬️🍂
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3
PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit — NephJC
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
www.nephjc.com
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky
www.nephjc.com/news/2025/9/ahaacc-htnguide
www.nephjc.com/news/2025/9/ahaacc-htnguide
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
www.nephjc.com
Finally, the concurrent results of the ALCHEMIST trial (www.sciencedirect.co...) also showed that spironolactone did not reduce major cardiovascular events in older, high-risk hemodialysis patients. #NephJC
Infographic by @nephroseeker.medsky.socia
Infographic by @nephroseeker.medsky.socia
T3b:
But… theoretical reasons do not matter anymore since in this well done, large trial with absolutely no benefit of spironolactone in ESRD. Coupled with the risk of serious hyperkalemia, spironolactone should no longer be used for CV protection in ESRD. #NephJC
But… theoretical reasons do not matter anymore since in this well done, large trial with absolutely no benefit of spironolactone in ESRD. Coupled with the risk of serious hyperkalemia, spironolactone should no longer be used for CV protection in ESRD. #NephJC
T0e:
⚡ Additionally, aldosterone, via mineralocorticoid receptor activation, drives:
⬆️ Reactive oxygen species (ROS)
⬇️ Nitric oxide (NO)
⬆️ Pro-inflammatory cytokines
A perfect storm for vascular injury & CV risk in ESRD.
#NephJC
www.ahajournals.org/...
⚡ Additionally, aldosterone, via mineralocorticoid receptor activation, drives:
⬆️ Reactive oxygen species (ROS)
⬇️ Nitric oxide (NO)
⬆️ Pro-inflammatory cytokines
A perfect storm for vascular injury & CV risk in ESRD.
#NephJC
www.ahajournals.org/...
Reposted by Stephanie Torres
Join us 9/2/25 at 9pm EST.
We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations.
Invite your friends. #NephJC #NephSky
www.nephjc.com/news/achieve
We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations.
Invite your friends. #NephJC #NephSky
www.nephjc.com/news/achieve
In ESRD is spironolactone an overACHIEVEr? — NephJC
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
www.nephjc.com
ISN Quiz alert!!
📌HTN remains the leading global contributor to reno cardiovascular death and disability.
📌Take this evidence-based quiz from ISN SoMe team members to assess your knowledge and improve patient care. Here’s the link for the quiz: theisn.outgrow.us/HTN_2025
📌HTN remains the leading global contributor to reno cardiovascular death and disability.
📌Take this evidence-based quiz from ISN SoMe team members to assess your knowledge and improve patient care. Here’s the link for the quiz: theisn.outgrow.us/HTN_2025
Interactive Calculators & Quizzes
Easily create interactive experiences that increase conversion and bring traffic.
theisn.outgrow.us
#1 Today is World HTN Day!
🧑🤝🧑1.3 billion people live with HTN, but only 1 in 5 meet BP goals.
⚠️HTN silently drives stroke, heart & kidney failure—and 57% of global deaths.
Check this beautiful Infographic by @gabyneph.bsky.social
#ISNTweetorial #WorldHypertensionDay
🧑🤝🧑1.3 billion people live with HTN, but only 1 in 5 meet BP goals.
⚠️HTN silently drives stroke, heart & kidney failure—and 57% of global deaths.
Check this beautiful Infographic by @gabyneph.bsky.social
#ISNTweetorial #WorldHypertensionDay
#23 𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for next Space #WorldHypertensionDay: "Hypertension and the Kidneys."
@edgarvlermamd.bsky.social @hswapnil.medsky.social @myadla.bsky.social @dilushiwijay.bsky.social @ferarceamare.bsky.social
🗓️ May 22
🕑 3:00 pm CEST
⏰ Set your alarm here: twitter.com/i/spaces/1jM...
@edgarvlermamd.bsky.social @hswapnil.medsky.social @myadla.bsky.social @dilushiwijay.bsky.social @ferarceamare.bsky.social
🗓️ May 22
🕑 3:00 pm CEST
⏰ Set your alarm here: twitter.com/i/spaces/1jM...
